VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
SPRY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
SPRYARS Pharmaceuticals, Inc.
$4.07$404M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksSPRYQuarterly Balance Sheet

ARS Pharmaceuticals, Inc. (SPRY) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

ARS Pharmaceuticals, Inc. (SPRY) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

SPRY Balance Sheet

Quarterly statement

SPRY Balance Sheet

ARS Pharmaceuticals, Inc. (SPRY) balance sheet — 8-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Total Current Assets211.51M245.24M284.9M338.86M281.44M303.86M334.3M208.79M220.74M226.24M231.56M244.47M255.03M267.35M277.7M39.09M45.39M261.33M60.73M305.36M
Cash & Short-Term Investments143.84M200.97M244.99M288.21M240.13M275.73M314.02M204.62M218.74M223.63M228.36M241.9M252.21M264.55M274.38M37.32M44.59M253.85M60.06M300.66M
Cash Only8.16M24.32M41.32M59.56M51.54M39.86M50.82M39.66M36.63M56.01M70.97M60.53M119.02M87.86M210.52M37.32M44.59M233.99M60.06M300.66M
Short-Term Investments135.68M176.65M203.67M228.65M188.59M235.86M263.2M164.97M182.12M167.63M157.39M181.37M133.19M176.69M63.86M0019.86M00
Accounts Receivable46.84M29.46M26.35M37.69M26.08M10.27M9.16M1.24M542K618K795K814K0522K0035K01K0
Days Sales Outstanding103.15110.73104.8890.26105.25109.75.5339.62105.56----2.35K--6.86-0.12-
Inventory11.69M8.82M8.37M7.78M8.74M7.27M5.21M715K000000000000
Days Inventory Outstanding72.63123.03232.0392.78146.14138.8370.05587.32------------
Other Current Assets05.99M5.19M1.35M2.03M963K1.23M593K323K300K00962K01.01M1.18M07.49M04.7M
Total Non-Current Assets37.98M42.34M42.76M33.94M32.04M23.46M16.86M8.81M1.23M1.34M1.63M4.09M3.72M3.84M3.73M637K661K51.14M716K47.21M
Property, Plant & Equipment2.08M2.29M2.46M2.65M2.64M1.15M1.07M935K782K814K824K917K943K982K774K615K638K6.91M693K6.92M
Fixed Asset Turnover15.40x9.55x10.99x12.29x8.30x7.21x86.54x2.41x0.63x---0.01x0.02x-0.30x0.12x0.17x0.20x0.10x
Goodwill00000000000000000000
Intangible Assets13.9M14.18M14.45M14.73M13.16M7.49M7.68M7.88M446K528K0000000000
Long-Term Investments0000000000000000044.22M040.29M
Other Non-Current Assets22M25.87M25.84M16.56M16.24M14.82M8.11M000801K3.17M2.77M2.86M2.96M22K23K023K0
Total Assets249.5M287.57M327.65M372.8M313.47M327.32M351.15M217.6M221.97M227.58M233.19M248.56M258.75M271.19M281.44M39.73M46.05M312.47M61.45M352.56M
Asset Turnover0.13x0.07x0.08x0.09x0.05x0.02x0.30x0.01x0.00x---0.00x0.00x-0.00x0.00x0.00x0.00x0.00x
Asset Growth %-20.41%-12.14%-6.69%71.32%41.23%43.82%50.59%-12.45%-14.22%-16.08%-17.14%525.58%461.91%-13.21%358.02%-88.73%-87.45%-18.24%--
Total Current Liabilities60.86M49.61M39.15M50.88M45.6M27.62M23.44M16.62M6.72M3.71M2.39M11.18M10.05M9.84M5.44M8.33M7.46M14.81M8.19M15.35M
Accounts Payable59.73M4.71M5.72M8.38M15.56M4.09M9.87M8.28M3.27M839K759K2.97M1.5M2.58M1.66M2.46M1.94M2.63M1.79M1.72M
Days Payables Outstanding228.2374.67202.66134.45179.43155.32214.474.74K27.1213.8950.3468.4525.7629.5753.3553.3647.7836.6541.231.66
Short-Term Debt000583K000000237K235K0232K03.52M3.5M1.12M3.48M1.09M
Deferred Revenue (Current)535K757K609K0746K540K557K00000010K00344K01.46M0
Other Current Liabilities596K592K588K41.91M4.31M4.73M2.29M2.58M1.5M1.07M1.08M5.83M278K5.83M1.46M844K472K11.05M660K12.54M
Current Ratio3.48x4.94x7.28x6.66x6.17x11.00x14.26x12.56x32.82x60.90x96.85x21.87x25.37x27.18x51.01x4.69x6.08x17.65x7.42x19.90x
Quick Ratio3.28x4.77x7.06x6.51x5.98x10.74x14.04x12.52x32.82x60.90x96.85x21.87x25.37x27.18x51.01x4.69x6.08x17.65x7.42x19.90x
Cash Conversion Cycle-52.46159.09134.2548.5971.9693.2-138.89-4.12K------------
Total Non-Current Liabilities176.12M176.65M174.25M174.27M75.55M70.72M70.92M00037K92K146K199K3.1M5.52M82.62M4.43M84.53M5.08M
Long-Term Debt171.6M96.52M96.37M949K000000000002.28M3.17M04.93M0
Capital Lease Obligations00001.07M0000037K92K146K199K251K300K349K4.43M480K5.08M
Deferred Tax Liabilities00000000000000000000
Other Non-Current Liabilities3.4M79.15M76.75M173.32M73.38M69.38M69.38M00000002.85M2.93M76.12M076.12M0
Total Liabilities236.98M226.26M213.39M225.15M121.15M98.34M94.36M16.62M6.72M3.71M2.43M11.27M10.2M10.04M8.55M13.85M90.08M19.24M92.72M20.43M
Total Debt171.6M96.52M96.37M1.53M1.66M73K42K102K160K217K274K327K379K431K481K6.33M7.25M5.55M9.03M6.17M
Net Debt163.44M72.2M55.06M-58.02M-49.88M-39.79M-50.77M-39.55M-36.47M-55.79M-70.7M-60.2M-118.64M-87.43M-210.04M-30.99M-37.34M-228.44M-51.03M-294.49M
Debt / Equity13.72x1.57x0.84x0.01x0.01x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.24x-0.02x-0.02x
Debt / EBITDA------0.00x-------------
Net Debt / EBITDA-------1.08x-------------
Interest Coverage-24.15x-23.83x------------------
Total Equity12.51M61.31M114.26M147.66M192.32M228.97M256.8M200.98M215.24M223.87M230.76M237.28M248.55M261.15M272.89M25.88M-44.03M293.23M-31.27M332.13M
Equity Growth %-93.49%-73.22%-55.51%-26.53%-10.65%2.28%11.28%-15.3%-13.4%-14.28%-15.44%816.72%664.48%-10.94%972.7%-92.21%-112.59%-20.44%--
Book Value per Share0.130.621.161.491.962.342.622.072.222.322.402.482.622.772.900.28-0.473.13-0.899.49
Total Shareholders' Equity12.51M61.31M114.26M147.66M192.32M228.97M256.8M200.98M215.24M223.87M230.76M237.28M248.55M261.15M272.89M25.88M-44.03M293.23M-31.27M332.13M
Common Stock10K10K10K10K10K10K10K10K10K10K10K9K9K9K9K260K260K4K3K4K
Retained Earnings-417.56M-355.22M-294.6M-253.28M-202.13M-157.25M-123.31M-173.24M-154.11M-141.59M-131.3M-124.14M-109.27M-91.9M-76.94M-62.51M-55.93M-210.84M-42.26M-162.75M
Treasury Stock00000000000000000000
Accumulated OCI-140K-96K125K-7K-46K72K220K339K-145K-124K49K-161K-180K68K407K00-1.25M0-34K
Minority Interest00000000000000000000